Ligand Pharmaceuticals reported $-40543000 in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Amgen USD 3.6B 147M Jun/2025
Arrowhead Research USD -159327000 556.67M Jun/2025
Baxter International USD 325M 251M Mar/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Glaxosmithkline GBP 3.23B 1.54B Jun/2025
Insmed USD -297127000 71.11M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Ligand Pharmaceuticals USD -40543000 50.88M Mar/2025
MacroGenics USD -33437000 17.35M Jun/2025
Merck USD 7.74B 625M Mar/2025
Pacira USD 54.32M 24.98M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Veracyte USD 35.78M 29.25M Jun/2025